Timing of high-dose rate brachytherapy with external beam radiotherapy in intermediate and high-risk localized prostate cancer (THEPCA) patients and its effects on toxicity and quality of life: ...
TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one year, ...
XIANGTAN, China, Feb. 23, 2017 /PRNewswire/ -- Infections and diseases of the prostate (otherwise known as prostatitis) can cause significant physical and mental problems to those suffering. Many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results